improved levonorgestrel-containing composition only for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
Hermann Osterwald,Michael Oettel,Prithi S. Kochhar
申请号：
BR112015010650
公开号：
BR112015010650A2
申请日:
2013.11.04
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
"improved levonorgestrel-only composition containing optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation" comprising an optimized composition containing only levonorgestrel for improved continuous oral contraception with consequences for suitable and content-appropriate pharmaceutical preparations defined as levonorgestrel. The invention relates to a pharmaceutical composition for oral contraception for a woman of childbearing age consisting of 60 to 100 µg of levonorgestrel and one or more acceptable pharmaceutical carriers and excipients. Furthermore, the invention relates to a pharmaceutical preparation for oral contraception consisting of numerous separately packaged and individually removable daily dosage units intended for consecutive daily oral administration, each dosage unit consisting of 60 to 100 µg levonorgestrel and one or more more acceptable pharmaceutical carriers and excipients. Additionally, the invention relates to a dosage regimen, ie the use of an oral dosage form consisting of 60 to 100 µg levonorgestrel and one or more acceptable pharmaceutical vehicles and excipients per oral contraceptive dosage unit for a woman. of childbearing age when administering a dosage unit daily during the full cycle of menstruation. 1/1resumo “composição contendo somente levonorgestrel melhorada para contracepção oral otimizada com conteúdo definido de levonorgestrel, regime de dosagem e preparo farmacêutico”, compreendendo uma composição otimizada contendo somente levonorgestrel para contracepção oral contínua melhorada com consequências para preparos farmacêuticos adequados para a mesma finalidade e com conteúdo definido de levonorgestrel. a invenção refere-se a uma composição farmacêutica para contracepção oral para uma mulher de idade fértil consistindo em 60 até 100 µg de levonorgestrel e um ou mais veículos e excipientes farmacêuticos aceitáveis. além do mais, a invenção refere-se a um preparo farmac
